Related Experiment Video
Updated: Mar 31, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Update on Diffuse Lung Disease in Children
Timothy J Vece1, Lisa R Young2
1Section of Pulmonology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
Insights
Children's interstitial lung disease comprises rare, diverse lung disorders affecting gas exchange. Recent advances improve understanding, diagnosis, and treatment of these serious pediatric conditions.
Area of Science:
- Pediatric Pulmonology
- Rare Diseases
- Respiratory Medicine
Background:
- Diffuse lung diseases in children (DLD) encompass rare, heterogeneous conditions impacting pulmonary gas exchange.
- Collectively, these DLDs contribute to substantial pediatric morbidity, mortality, and healthcare resource use.
- Despite individual rarity, the collective impact of DLD necessitates focused research and clinical attention.
Purpose of the Study:
- To review recent significant advancements in the understanding of pediatric diffuse lung diseases.
- To summarize updated diagnostic approaches for children's interstitial lung disease.
- To outline current and emerging treatment strategies for diffuse lung diseases in children.
Main Methods:
- Comprehensive literature review of recent studies on pediatric diffuse lung diseases.
- Analysis of genetic discoveries and their implications for DLD.
- Evaluation of newly developed clinical practice guidelines for DLD management.
Main Results:
- Significant progress has been made in identifying genetic underpinnings of various DLDs.
- Clinical practice guidelines have been established, aiding standardized diagnosis and management.
- Advances in understanding disease mechanisms are paving the way for targeted therapies.
Conclusions:
- Recent breakthroughs enhance the comprehension of DLD pathophysiology.
- Improved diagnostic tools and genetic insights are transforming patient care.
- The field is evolving towards more personalized and effective treatment paradigms for children with diffuse lung diseases.
Abstract:
Diffuse lung diseases in children, also called children's interstitial lung disease, are a diverse group of rare disorders that cause disturbances of gas exchange in the lungs. Although individually rare, there are many different forms of diffuse lung disease in children, and collectively these disorders are associated with significant morbidity and mortality, as well as health-care resource utilization. Over the past several years, there have been many significant advances in the field, including genetic discoveries and the development of clinical practice guidelines. This review summarizes recent advances in the understanding, diagnosis, and treatment of diffuse lung diseases in children.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
07:10Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
Published on: May 20, 2019